Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00228-020-03020-w.pdf
Reference34 articles.
1. Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, Ray AS, Cihlar T, Siegel D, Mackman RL, Clarke MO, Baric RS, Denison MR (2018) Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio 9(2):e00221–e00218. https://doi.org/10.1128/mBio.00221-18
2. Choy KT, Yin-Lam Wong A, Kaewpreedee P, Sia SF, Chen D, Yan Hui KP, Wing Chu DK, Wai Chan MC, Pak-Hang Cheung P, Huang X, Peiris M, Yen HL (2020) Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antivir Res 104786:104786. https://doi.org/10.1016/j.antiviral.2020.104786
3. Lapadula G (2020) Five reasons why data on compassionate use of remdesivir deserved publication (and are worth reading). Swiss Med Wkly 150:w20265. https://doi.org/10.4414/smw.2020.20265
4. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 105949:105949. https://doi.org/10.1016/j.ijantimicag.2020.105949
5. Mehra MR, Desai SS, Ruschitzka F, Patel AN (2020) Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. In: Lancet. https://doi.org/10.1016/S0140-6736(20)31180-6
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model;Cardiovascular Toxicology;2024-06-08
2. Population Pharmacokinetics of Cabozantinib in Metastatic Renal Cell Carcinoma Patients: Towards Drug Expenses Saving Regimens;Clinical Pharmacokinetics;2024-06
3. Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID‐19;Fundamental & Clinical Pharmacology;2024-02-11
4. Lack of antiviral activity of probenecid in vitro and in Syrian golden hamsters;Journal of Antimicrobial Chemotherapy;2023-11-23
5. Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-study;BMC Pharmacology and Toxicology;2023-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3